Shao-Lee Lin, CEO of Cue Biopharma CUE, has filed 0 purchases and 3 sales on the open market. The latest trade was on 06/01.

SL

SL

Shao-Lee Lin

CEO

Company

Cue Biopharma CUE

First filing

23/05/04

Trades

34 trades

Buys / sales

0 / 3

12-month net buying

No record

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AC Acelyrin	Open-market sale	24/04/01	24/04/03	9,961 sh	$6.63	$66,041.43	−0.6%
AC Acelyrin	Open-market sale	24/02/20	24/02/22	15,701 sh	$7.60	$119,327.6	−1.0%
AC Acelyrin	Open-market sale	24/01/02	24/01/04	10,691 sh	$7.41	$79,220.31	−0.7%